SCHEDULE 13G: TD Securities (USA) LLC Discloses 8.9% Stake in OneMedNet Corporation via Warrants
Schedule 13G Filing
TD Securities (USA) LLC, as successor to Cowen and Company, LLC, has disclosed a beneficial ownership of 8.9% in OneMedNet Corporation, primarily through warrants.
Summary
- TD Securities (USA) LLC (TDS) has reported beneficial ownership of 2,970,100 shares of OneMedNet Corporation's Common Stock.
- This ownership represents 8.9% of OneMedNet Corporation's outstanding Common Stock.
- The beneficial ownership is comprised solely of shares issuable upon the exercise of warrants held by TDS.
- These warrants have an exercise price of $11.50 per share and are currently exercisable.
- The percentage calculation is based on 30,572,831 shares of Common Stock reported outstanding by OneMedNet in its Amendment No. 3 to Form S-1, plus the 2,970,100 warrants.
- TDS holds sole voting and dispositive power over these shares.
- TDS became the successor in interest to Cowen and Company, LLC (Cowen) through a merger effective December 9, 2024, with the shares previously owned by Cowen.
- The filing is jointly made by TDS, Cowen, Toronto Dominion Holdings USA Inc. (TDH), TD Group US Holdings LLC (TD GUS), and Toronto Dominion Bank (TD Bank), reflecting their corporate ownership structure where TD Bank ultimately owns TDS through intermediate holding companies.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership, which is neutral in sentiment. It does not contain positive or negative operational news for the issuer.
Future Outlook
The document does not contain any forward-looking statements or guidance regarding OneMedNet Corporation's future operations or financial performance.
Industry Context
This filing is a standard disclosure of significant beneficial ownership by a financial institution in a publicly traded company. It reflects an investment position rather than operational or strategic industry trends for OneMedNet Corporation.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder's stake, which could influence market perception or trading activity.
- Investors: Offers insight into the ownership structure and the presence of a large financial institution as a beneficial owner.
Key Dates
| Date | Description |
|---|---|
| 2024-12-09 | Effective date of the merger where TD Securities (USA) LLC became successor in interest to Cowen and Company, LLC. |
| 2024-12-31 | Date of event which requires the filing of this statement. |
| 2025-01-31 | Date OneMedNet Corporation filed Amendment No. 3 to its registration statement on Form S-1, reporting 30,572,831 shares of Common Stock outstanding. |
| 2025-02-11 | Date the Schedule 13G statement was signed and filed. |
Keywords
OneMedNet Corporation, TD Securities (USA) LLC, Cowen and Company LLC, Schedule 13G, Beneficial Ownership, Common Stock, Warrants, SEC Filing, Institutional Investor, Healthcare Technology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.